Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1998 Nov;169(5):276–279.

Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.

V K Dhawan 1, R Nachum 1, N Bhat 1, L Tolbert 1, M Agrawal 1
PMCID: PMC1305316  PMID: 9830355

Abstract

We studied fecal colonization with vancomycin-resistant enterococci (VRE) in 89 HIV-infected nonhospitalized patients ages 24 to 62 years, including 70 (79%) men (including 41 homosexual and 5 bisexual men) and 19 (21%) women. Of the 89 patients, 61 (69%) were black, 25 (28%) Hispanic, and 3 (3%) white; 53 (60%) had history of ongoing or recent antibacterial therapy with trimethoprim/sulfamethoxazole (29), clarithromycin (18), amoxicillin (7), ofloxacin (3), and metronidazole, doxycycline, dicloxacillin, and cephalexin (1 each). VRE were not isolated from any of the patients studied.

Full text

PDF
276

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bates J., Jordens J. Z., Griffiths D. T. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother. 1994 Oct;34(4):507–514. doi: 10.1093/jac/34.4.507. [DOI] [PubMed] [Google Scholar]
  2. Boyle J. F., Soumakis S. A., Rendo A., Herrington J. A., Gianarkis D. G., Thurberg B. E., Painter B. G. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol. 1993 May;31(5):1280–1285. doi: 10.1128/jcm.31.5.1280-1285.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chenoweth C., Schaberg D. The epidemiology of enterococci. Eur J Clin Microbiol Infect Dis. 1990 Feb;9(2):80–89. doi: 10.1007/BF01963631. [DOI] [PubMed] [Google Scholar]
  4. Coque T. M., Tomayko J. F., Ricke S. C., Okhyusen P. C., Murray B. E. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother. 1996 Nov;40(11):2605–2609. doi: 10.1128/aac.40.11.2605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Edmond M. B., Ober J. F., Weinbaum D. L., Pfaller M. A., Hwang T., Sanford M. D., Wenzel R. P. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995 May;20(5):1126–1133. doi: 10.1093/clinids/20.5.1126. [DOI] [PubMed] [Google Scholar]
  6. Gordts B., Van Landuyt H., Ieven M., Vandamme P., Goossens H. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol. 1995 Nov;33(11):2842–2846. doi: 10.1128/jcm.33.11.2842-2846.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Handwerger S., Raucher B., Altarac D., Monka J., Marchione S., Singh K. V., Murray B. E., Wolff J., Walters B. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993 Jun;16(6):750–755. doi: 10.1093/clind/16.6.750. [DOI] [PubMed] [Google Scholar]
  8. Klare I., Heier H., Claus H., Böhme G., Marin S., Seltmann G., Hakenbeck R., Antanassova V., Witte W. Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist. 1995 Fall;1(3):265–272. doi: 10.1089/mdr.1995.1.265. [DOI] [PubMed] [Google Scholar]
  9. Klare I., Heier H., Claus H., Reissbrodt R., Witte W. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett. 1995 Jan 15;125(2-3):165–171. doi: 10.1111/j.1574-6968.1995.tb07353.x. [DOI] [PubMed] [Google Scholar]
  10. Klare I., Heier H., Claus H., Witte W. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett. 1993 Jan 1;106(1):23–29. doi: 10.1111/j.1574-6968.1993.tb05930.x. [DOI] [PubMed] [Google Scholar]
  11. Leclercq R., Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis. 1997 Apr;24(4):545–556. doi: 10.1093/clind/24.4.545. [DOI] [PubMed] [Google Scholar]
  12. Leclercq R., Derlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988 Jul 21;319(3):157–161. doi: 10.1056/NEJM198807213190307. [DOI] [PubMed] [Google Scholar]
  13. Linden P. K., Pasculle A. W., Manez R., Kramer D. J., Fung J. J., Pinna A. D., Kusne S. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis. 1996 Apr;22(4):663–670. doi: 10.1093/clinids/22.4.663. [DOI] [PubMed] [Google Scholar]
  14. Livornese L. L., Jr, Dias S., Samel C., Romanowski B., Taylor S., May P., Pitsakis P., Woods G., Kaye D., Levison M. E. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992 Jul 15;117(2):112–116. doi: 10.7326/0003-4819-117-2-112. [DOI] [PubMed] [Google Scholar]
  15. Montecalvo M. A., Horowitz H., Gedris C., Carbonaro C., Tenover F. C., Issah A., Cook P., Wormser G. P. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother. 1994 Jun;38(6):1363–1367. doi: 10.1128/aac.38.6.1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Moreno F., Grota P., Crisp C., Magnon K., Melcher G. P., Jorgensen J. H., Patterson J. E. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis. 1995 Nov;21(5):1234–1237. doi: 10.1093/clinids/21.5.1234. [DOI] [PubMed] [Google Scholar]
  17. Morris J. G., Jr, Shay D. K., Hebden J. N., McCarter R. J., Jr, Perdue B. E., Jarvis W., Johnson J. A., Dowling T. C., Polish L. B., Schwalbe R. S. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med. 1995 Aug 15;123(4):250–259. doi: 10.7326/0003-4819-123-4-199508150-00002. [DOI] [PubMed] [Google Scholar]
  18. Murray B. E. The life and times of the Enterococcus. Clin Microbiol Rev. 1990 Jan;3(1):46–65. doi: 10.1128/cmr.3.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Noskin G. A., Cooper I., Peterson L. R. Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization. Arch Intern Med. 1995 Jul 10;155(13):1445–1447. [PubMed] [Google Scholar]
  20. Rubin L. G., Tucci V., Cercenado E., Eliopoulos G., Isenberg H. D. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol. 1992 Dec;13(12):700–705. doi: 10.1086/648342. [DOI] [PubMed] [Google Scholar]
  21. Schaberg D. R., Culver D. H., Gaynes R. P. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991 Sep 16;91(3B):72S–75S. doi: 10.1016/0002-9343(91)90346-y. [DOI] [PubMed] [Google Scholar]
  22. Spera R. V., Jr, Farber B. F. Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen. Drugs. 1994 Nov;48(5):678–688. doi: 10.2165/00003495-199448050-00003. [DOI] [PubMed] [Google Scholar]
  23. Spera R. V., Jr, Farber B. F. Multiply-resistant Enterococcus faecium. The nosocomial pathogen of the 1990s. JAMA. 1992 Nov 11;268(18):2563–2564. [PubMed] [Google Scholar]
  24. Torres C., Reguera J. A., Sanmartin M. J., Pérez-Díaz J. C., Baquero F. vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother. 1994 Mar;33(3):553–561. doi: 10.1093/jac/33.3.553. [DOI] [PubMed] [Google Scholar]
  25. Uttley A. H., Collins C. H., Naidoo J., George R. C. Vancomycin-resistant enterococci. Lancet. 1988 Jan 2;1(8575-6):57–58. doi: 10.1016/s0140-6736(88)91037-9. [DOI] [PubMed] [Google Scholar]
  26. Van der Auwera P., Pensart N., Korten V., Murray B. E., Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis. 1996 May;173(5):1129–1136. doi: 10.1093/infdis/173.5.1129. [DOI] [PubMed] [Google Scholar]
  27. Vandamme P., Vercauteren E., Lammens C., Pensart N., Ieven M., Pot B., Leclercq R., Goossens H. Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol. 1996 Oct;34(10):2572–2576. doi: 10.1128/jcm.34.10.2572-2576.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wells C. L., Juni B. A., Cameron S. B., Mason K. R., Dunn D. L., Ferrieri P., Rhame F. S. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis. 1995 Jul;21(1):45–50. doi: 10.1093/clinids/21.1.45. [DOI] [PubMed] [Google Scholar]
  29. Zervos M. J., Bacon A. E., 3rd, Patterson J. E., Schaberg D. R., Kauffman C. A. Enterococcal superinfection in patients treated with ciprofloxacin. J Antimicrob Chemother. 1988 Jan;21(1):113–115. doi: 10.1093/jac/21.1.113. [DOI] [PubMed] [Google Scholar]
  30. van den Bogaard A. E., Jensen L. B., Stobberingh E. E. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med. 1997 Nov 20;337(21):1558–1559. doi: 10.1056/NEJM199711203372117. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES